Deep Immune Profiling of Patients with <i>STAT1</i> Gain-of-Function: Revealing New Mechanisms of Pathology
Saara Kaviany(Vanderbilt University Medical Center), Jeffrey C. Rathmell(University of Chicago), Jonathan M. Irish(Vanderbilt University), Todd Bartowiak(Vanderbilt University), Jim A. Connelly(Vanderbilt University Medical Center), Daniel E. Dulek(Vanderbilt University Medical Center), Yasmin Khan(Vanderbilt University Medical Center)
Cited by 2
Related Papers
Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
|The Journal of Immunology|2011|2k
Glucose Uptake Is Limiting in T Cell Activation and Requires CD28-Mediated Akt-Dependent and Independent Pathways
|The Journal of Immunology|2008|836
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation
|Journal of Clinical Investigation|2014|717